In vitro effects of trastuzumab and vinorelbine in trastuzumab-resistant breast cancer cells

被引：0
|
作者：
Rita Nahta
Francisco J. Esteva
机构：
[1] The University of Texas M. D. Anderson Cancer Center,Department of Breast Medical Oncology
[2] The University of Texas M. D. Anderson Cancer Center,Department of Molecular and Cellular Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2004年 / 53卷
关键词：
Apoptosis; Dose-response; Herceptin; Resistance; SKBR3;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：186 / 190
页数：4
相关论文
共 50 条
  • [31] HER2-Specific T Lymphocytes Kill both Trastuzumab-Resistant and Trastuzumab-Sensitive Breast Cell Lines In Vitro
    Xiao‐lin Lin 1
    Chinese Journal of Cancer Research, 2012, 24 (02) : 143 - 150
  • [32] Liposome-enabled bufalin and doxorubicin combination therapy for trastuzumab-resistant breast cancer with a focus on cancer stem cells
    Gao, Yu
    Shelling, Andrew N.
    Nolan, Emma
    Porter, David
    Leung, Euphemia
    Wu, Zimei
    JOURNAL OF LIPOSOME RESEARCH, 2024, 34 (03) : 489 - 506
  • [33] Nuclear Function of ErbB-2/ErbB-3 Heterodimers in Trastuzumab-Resistant Breast Cancer Cells
    Cordo Russo, Rosalia Inas
    Beguelin, Wendy
    Diaz Flaque, Maria Celeste
    Chiauzzi, Violeta A.
    Venturutti, Leandro
    Galigniana, Natalia M.
    Proietti, Cecilia J.
    Charreau, Eduardo H.
    Schillaci, Roxana
    Virginia Elizalde, Patricia
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [34] Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer
    Joensuu, H
    Kellokumpu-Lehtinen, P
    Bono, P
    Alanko, T
    Kataja, V
    Asola, R
    Utriainen, T
    Kokko, R
    Hemminki, A
    Tarkkanen, M
    Turpeenniemi-Hujanen, T
    Jyrkkiö, S
    Flander, M
    Helle, L
    Ingalsuo, S
    Johansson, K
    Jääskeläinen, A
    Pajunen, M
    Rauhala, M
    Kaleva-Kerola, J
    Salminen, T
    Leinonen, M
    Elomaa, I
    Isola, J
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (08): : 809 - 820
  • [35] ESE-1 Knockdown Attenuates Growth in Trastuzumab-resistant HER2+ Breast Cancer Cells
    Kar, Adwitiya
    Liu, Bolin
    Gutierrez-Hartmann, Arthur
    ANTICANCER RESEARCH, 2017, 37 (12) : 6583 - 6591
  • [36] Targeting trastuzumab-resistant breast cancer cells with a lentivirus engineered to bind antibodies that recognize HER-2
    Kai-xin Zhang
    Connie Kim
    Elaine Chow
    Irvin S. Y. Chen
    William Jia
    Paul S. Rennie
    Breast Cancer Research and Treatment, 2011, 125 : 89 - 97
  • [37] Targeting trastuzumab-resistant breast cancer cells with a lentivirus engineered to bind antibodies that recognize HER-2
    Zhang, Kai-xin
    Kim, Connie
    Chow, Elaine
    Chen, Irvin S. Y.
    Jia, William
    Rennie, Paul S.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (01) : 89 - 97
  • [38] Trastuzumab and vinorelbine (TV) in early stages of breast cancer
    Ferrario, C.
    Wong, A.
    Bouganim, N.
    Gao, T.
    Aloyz, R.
    Panasci, L. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [39] Trastuzumab and Vinorelbine combination in the treatment of metastatic breast cancer
    Bayo, J. L.
    Mayordomo, J. I.
    Rovira, P. Sanchez
    Gonzalez, E.
    Bueno, J. M. Garcia
    Ramos, M.
    Crespo, C.
    Illarramendi, J.
    Valerdi, J.
    Palomo, A. Garcia
    EJC SUPPLEMENTS, 2004, 2 (03): : 130 - 130
  • [40] Trastuzumab-resistant HER2-Driven breast cancer cells are sensitive to epigallocatechin-3 gallate
    Eddy, Sean F.
    Kane, Susan E.
    Sonenshein, Gail E.
    CANCER RESEARCH, 2007, 67 (19) : 9018 - 9023
12345